We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacotherapics Advice in Guidelines for COVID-19.
- Authors
Chen, Zhang-Ren; Zhou, Ying; Liu, Jin; Peng, Hong-Wei; Zhou, Jian; Zhong, Hai-Li; Liu, Li-Li; Lai, Ming-Fang; Wei, Xiao-Hua; Wen, Jin-Hua
- Abstract
Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs.
- Subjects
ITALY; COVID-19; NONPRESCRIPTION drugs; GUIDELINES
- Publication
Frontiers in Pharmacology, 2020, Vol 11, p1
- ISSN
1663-9812
- Publication type
Article
- DOI
10.3389/fphar.2020.00950